Form 4 for CVS CVS Health
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-31 · accession 0001127602-25-016519 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-03 | 2025-05-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $64.04 | +21.9K | 21.9K | New | +$1.40M |
| D | 2025-06-03 | 2025-05-31 | CVS | Newman Brian | EVP, CFO | A - Grant | $0.00 | +94.8K | 94.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSUs) | 2025-05-31 | A | A | 21,861 | $64.04 | 21,861 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-05-31 | A | A | 94,786 | $0.00 | 94,786 | D | $64.04 · 2026-05-31 to 2035-05-31 | 94,786 Common Stock | (F2) Option becomes exercisable in four equal annual installments, commencing 5/31/2026. |